MedTrace Logo

Corifollitropin Alfa on D5 Versus D7 After Contraceptive Pill

NCT02490150 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2017-05-16

No results posted yet for this study

Summary

To evaluate if the administration of corifollitropin alfa on day 7 instead of on day 5 after pre-treatment with oral contraceptive pill results in a reduced total rFSH (recombinant follicle stimulating hormone ) consumption in a GnRH antagonist protocol in donors.

Conditions

  • Oocyte Donation

Interventions

DRUG

Corifollitropin alfa

Sponsors & Collaborators

  • Francisca Martínez

    collaborator UNKNOWN

  • Buenaventura Coroleu

    collaborator UNKNOWN

  • Elisabet Clua

    collaborator UNKNOWN

  • Ignacio Rodríguez

    collaborator UNKNOWN

  • Fundacion Dexeus

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02490150 on ClinicalTrials.gov